QGenda

Atlanta

400 Total Employees

Year Founded: 2006

View Website

QGenda Company Growth, Stability & Outlook

Updated on September 17, 2026

This page summarizes recurring themes identified from responses generated by popular LLMs to common candidate questions about QGenda and has not been reviewed or approved by QGenda.

What's the stability & growth outlook for QGenda?

Strengths in market leadership, product expansion, and capital backing are accompanied by questions about the pace and transparency of recent growth. Together, these dynamics suggest a well-positioned company with significant resources, while stakeholders may monitor whether momentum proves durable beyond acquisition-led expansion.

Key Insight for Candidates

Defining tradeoff: QGenda pairs niche-market leadership with an M&A-heavy growth strategy under a large parent. That means high stability and resources, but day-to-day work centers on integrating acquired products and enterprise systems, with added process and complexity. Candidates should expect integration-heavy roadmaps rather than greenfield builds.

Evidence in Action

Hearst-Backed Roadmap Cadence — In late 2024, Acquisition by Hearst and integration within Hearst Health establish enterprise-level funding and governance rhythms. Employees gain planning stability, clearer prioritization, and access to parent-company resources that de-risk roadmaps and sustain long-term growth.
ProviderCloud Unified Roadmap — ProviderCloud, used by 4,500+ organizations and 700,000+ providers, anchors a single, end-to-end workforce management roadmap. Employees see coherent priorities, fewer conflicting backlogs, and clearer role alignment as features and acquisitions fold into one platform.

Positive Themes About QGenda

Strong Market Position & Advantage: Industry recognition such as Best in KLAS across physician, nurse/staff scheduling, and time & attendance, coupled with adoption by thousands of hospitals and health systems, underscores a leading position in healthcare workforce management. The platform’s scale across 4,500+ organizations and more than 45 specialties is repeatedly highlighted as evidence of category leadership.
Investor Backing & Capital Strength: Acquisition by Hearst and prior support from Francisco Partners and ICONIQ Growth are presented as substantial backing that enhances stability and resourcing. Placement within Hearst Health is cited as enabling continued scaling and product development.
Product Line Growth: The portfolio has expanded from automated physician scheduling into a unified workforce management platform spanning credentialing, time and attendance, capacity management, and analytics. Targeted acquisitions—such as New Innovations and Schedule360—extend coverage into graduate medical education and nurse/staff scheduling.

Considerations About QGenda

Short-Term or Unsustainable Growth: Growth descriptions frequently emphasize acquisitions and ecosystem integrations, while recent workforce data indicates only modest year-over-year headcount increases. Public visibility into revenue momentum post-acquisition is limited and third-party estimates vary widely, reducing clarity on the durability of the trajectory.

NEW

What does AI tell candidates about your employer brand?

Get your free AI reputation report today.

See AI Report

These insights are generated using AI and may not reflect internal data or verified company information. They are intended solely for general informational purposes and should not be considered a definitive assessment of the company’s reputation. If you are a representative of this company, and would like this page to be removed, you may contact us via this form.